Literature DB >> 18234699

Psychosocial treatment programs for people with both severe mental illness and substance misuse.

M Cleary1, G E Hunt, S Matheson, N Siegfried, G Walter.   

Abstract

Over 50% of people with a severe mental illness also use illicit drugs and/or alcohol at hazardous levels. This review is based on the findings of 25 randomized controlled trials which assessed the effectiveness of psychosocial interventions, offered either as one-off treatments or as an integrated or nonintegrated program, to reduce substance use by people with a severe mental illness. The findings showed that there was no consistent evidence to support any one psychosocial treatment over another. Differences across trials with regard to outcome measures, sample characteristics, type of mental illness and substance used, settings, levels of adherence to treatment guidelines, and standard care all made pooling results difficult. More quality trials are required that adhere to proper randomization methods; use clinically valuable, reliable, and validated measurement scales; and clearly report data, including retention in treatment, relapse, and abstinence rates. Future trials of this quality will allow a more thorough assessment of the efficacy of psychosocial interventions for reducing substance use in this challenging population.

Entities:  

Mesh:

Year:  2008        PMID: 18234699      PMCID: PMC2632415          DOI: 10.1093/schbul/sbm165

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  6 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 2.  Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials.

Authors:  Maria Donald; Jo Dower; David Kavanagh
Journal:  Soc Sci Med       Date:  2005-03       Impact factor: 4.634

3.  CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews.

Authors:  David L Turpin
Journal:  Am J Orthod Dentofacial Orthop       Date:  2005-12       Impact factor: 2.650

4.  Schizophrenia and co-occurring substance use disorder.

Authors:  Alan I Green; Robert E Drake; Mary F Brunette; Douglas L Noordsy
Journal:  Am J Psychiatry       Date:  2007-03       Impact factor: 18.112

5.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

Review 6.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  M Cleary; G Hunt; S Matheson; N Siegfried; G Walter
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  6 in total
  1 in total

1.  Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis.

Authors:  Carla A Green; Micah T Yarborough; Michael R Polen; Shannon L Janoff; Bobbi Jo H Yarborough
Journal:  J Dual Diagn       Date:  2014-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.